The carriers who had at least one variant allele of BMAL1 rs2279297 (p = 0.05) or were a recessive homozygote of CRY2 rs3824872 (p = 0.0004), had a significantly decreased gene expression level in breast cancer tissue compared to the women with a dominant homozygous genotype. Here, CRY2 is linked to breast carcinoma.